/Investor DB

Medblue — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Basking Biosciencesbaskingbiosciences.cominAug 2020

Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease.

BiotechDigital HealthHealthtechMedical DevicesCary, US

Shahid Nimjee(Co-founder, Chief Scientific Officer and Stroke Clinical Lead)inBruce Sullenger(Co-founder)Julia Owens(Executive Officer, Director, Promoter)inRichard Shea(Executive Officer, Director, Promoter)in

BoardHannah Chang(Director)Aiden Aceves(Director)in

Co-investorsARCH Venture PartnersInsight PartnersBroadview VenturesSolas BioVenturesPlatanus VenturesRev1 Ventures+1 more

inSoma Bioinsomabio.comSeed · Jun 2020

inSoma Bio develops biomaterial products for reconstruction plastic surgery, enabling surgeons to use patients' own tissue instead of synthetic implants and fillers for breast and facial reconstruction procedures.

BiotechHealthtechMedical DevicesDurham, US

Stefan Roberts(Founder)inAshutosh Chilkoti(Founder)in

BoardScott Hollenbeck(Lead Medical Advisor, Co-Founder)inJuliana Blum(Director)Heather Brennan(Director)June S. Almenoff(Director)

Co-investorsDuke Capital PartnersFemHealth VenturesY Combinator360 CapitalAsymmetry VenturesDeep Ventures+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.